Business Wire
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan demonstrated meaningfully greater magnitude of progression-free survival benefit in patients with this... Read more.
Summit to Initiate HARMONi-7, a Phase III Trial in First-Line PD-L1 High, Advanced NSCLC, in Early 2025 Ivonescimab Is the First Drug to Achieve Clinically Mean... Read more.
Coalition Re to Offer Active Cyber Reinsurance via Two Products Supported by Aspen-led Capacity SAN FRANCISCO–(BUSINESS WIRE)–Coalition, the world... Read more.
Mean Change From Baseline in Disease Severity Score (DSS) Showed Significant Improvement with Molgramostim Compared with Placebo at Weeks 24 and 48 Responder An... Read more.
Bexicaserin achieved an overall median seizure reduction of 57.7% in countable motor seizures over an approximate 9-month treatment period Favorable safety and ... Read more.
IRVINE, Calif.–(BUSINESS WIRE)–The second day of the 11th Annual World Patient Safety, Science & Technology Summit, presented by the Patient Saf... Read more.
The firms emphasized that the removal of blanket exclusions would catalyze Ukraine’s growth and future reconstruction MONTE CARLO, Monaco–(BUSINESS WIRE... Read more.
The fashion designer selected the beloved bedding brand’s rarest fabrication for his Spring 2025 ready-to-wear collection at New York Fashion Week. NEW YORK... Read more.
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enstar Group Limited (NASDAQ: ESGR) to ... Read more.
PALO ALTO, Calif.–(BUSINESS WIRE)–GigCapital7 Corp. (NASDAQ: GIGGU) (the “Company”), a Cayman Islands exempted company, announced today that hol... Read more.